Stock Analysis

High Growth Tech Stocks In China Featuring Three Prominent Players

SZSE:300698
Source: Shutterstock

Amidst a backdrop of geopolitical tensions and fluctuating economic indicators, Chinese stocks have shown resilience, with indices like the Shanghai Composite and CSI 300 experiencing significant gains driven by optimism surrounding Beijing's support measures. In this environment, identifying high growth tech stocks involves assessing companies that can leverage supportive government policies and navigate the challenges of contracting manufacturing activity to sustain their momentum in an evolving market landscape.

Top 10 High Growth Tech Companies In China

NameRevenue GrowthEarnings GrowthGrowth Rating
Xi'an NovaStar Tech27.95%31.01%★★★★★★
Zhejiang Meorient Commerce Exhibition26.41%32.59%★★★★★★
Suzhou TFC Optical Communication32.62%32.32%★★★★★★
Zhongji Innolight32.62%31.72%★★★★★★
Range Intelligent Computing Technology Group23.53%29.96%★★★★★★
Shanghai BOCHU Electronic Technology27.74%28.58%★★★★★★
Cubic Sensor and InstrumentLtd24.24%38.87%★★★★★★
Eoptolink Technology43.31%44.06%★★★★★★
Bio-Thera Solutions26.85%117.16%★★★★★★
Huayi Brothers Media37.55%103.97%★★★★★★

Click here to see the full list of 255 stocks from our Chinese High Growth Tech and AI Stocks screener.

Underneath we present a selection of stocks filtered out by our screen.

DBAPPSecurity (SHSE:688023)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: DBAPPSecurity Co., Ltd. focuses on the research, development, manufacture, and sale of cybersecurity products in China with a market capitalization of CN¥5.65 billion.

Operations: DBAPPSecurity Co., Ltd. specializes in cybersecurity solutions, primarily generating revenue through the sale of its developed products in China. The company emphasizes research and development to enhance its product offerings, contributing significantly to its operations.

DBAPPSecurity, amid a challenging financial landscape, shows a promising shift towards profitability with expected earnings growth of 73.6% annually. This pivot is underscored by their recent half-year financials, where they narrowed their net loss significantly to CNY 275.61 million from CNY 408.66 million year-over-year and maintained steady revenue growth at 17.3%. Despite current unprofitability and high share price volatility, the company's R&D commitment is robust, aligning with its strategic focus on enhancing cybersecurity solutions in a rapidly evolving tech landscape in China. This dedication to innovation could potentially accelerate DBAPPSecurity's transition to profitability and fortify its market position against competitors in the high-stakes tech arena.

SHSE:688023 Earnings and Revenue Growth as at Oct 2024
SHSE:688023 Earnings and Revenue Growth as at Oct 2024

Shenzhen Qingyi Photomask (SHSE:688138)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Shenzhen Qingyi Photomask Limited is involved in the research, design, production, and sales of high precision masks in China with a market capitalization of CN¥6.60 billion.

Operations: Qingyi Photomask specializes in high precision mask production, leveraging its expertise in research and design to drive sales within China. The company's operations are supported by a market capitalization of CN¥6.60 billion, indicating its significant presence in the industry.

Shenzhen Qingyi Photomask has demonstrated a robust performance with its half-year revenue soaring to CNY 560.89 million from CNY 417.41 million, marking a significant year-over-year increase. This growth is complemented by an impressive surge in net income to CNY 88.91 million, up from CNY 53.37 million, reflecting strong operational efficiency and market demand for its photomask technology crucial for semiconductor manufacturing. Despite the broader Chinese tech sector's challenges, Qingyi's commitment to R&D spending is evident as it continues to innovate within the high-precision manufacturing space essential for tech advancements globally. With earnings expected to grow by 20.8% annually, slightly below the national average of 23.7%, Qingyi still outpaces many industry counterparts by maintaining substantial revenue growth at a forecasted rate of 21% per year against the market average of 13.4%.

SHSE:688138 Earnings and Revenue Growth as at Oct 2024
SHSE:688138 Earnings and Revenue Growth as at Oct 2024

Wanma Technology (SZSE:300698)

Simply Wall St Growth Rating: ★★★★★★

Overview: Wanma Technology Co., Ltd. focuses on the R&D, production, system integration, and sales of communication and medical information equipment with a market cap of CN¥6.63 billion.

Operations: The company generates revenue primarily through its communication and medical information equipment segments. It emphasizes research and development, production, and system integration to support its sales operations.

Wanma Technology, amidst a volatile market, has shown resilience with its earnings slightly dipping to CNY 15.97 million from CNY 16.79 million year-over-year, reflecting a tight operational control in challenging conditions. Despite a marginal decrease in sales and revenue, the company's commitment to innovation is evident with an R&D expense ratio that aligns closely with industry leaders striving for technological advancements. Notably, Wanma's future looks promising as it is poised for substantial growth with expected annual revenue and earnings increases of 35.6% and 47.8%, respectively—outpacing the broader Chinese tech sector's averages significantly. This robust forecast is supported by strategic decisions made during their recent extraordinary shareholders meeting focusing on capital increases and leadership adjustments to bolster their market position further.

SZSE:300698 Earnings and Revenue Growth as at Oct 2024
SZSE:300698 Earnings and Revenue Growth as at Oct 2024

Next Steps

Want To Explore Some Alternatives?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Wanma Technology might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com